Reuters logo
BRIEF-Amgen receives positive CHMP opinion to expand use of Nplate in pediatric patients with chronic immune thrombocytopenic purpura
2017年11月10日 / 下午12点49分 / 7 天内

BRIEF-Amgen receives positive CHMP opinion to expand use of Nplate in pediatric patients with chronic immune thrombocytopenic purpura

Nov 10 (Reuters) - Amgen Inc

* Amgen receives positive CHMP opinion to expand use of Nplate® (romiplostim) in pediatric patients with chronic immune thrombocytopenic purpura

* Amgen Inc - ‍positive CHMP opinion was based on five studies evaluating safety and efficacy of Nplate in children with ITP​, among other things Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below